Attached files

file filename
10-K/A - 10-K/A - INTERCEPT PHARMACEUTICALS, INC.v438200_10ka.htm
EX-31.3 - EXHIBIT 31.3 - INTERCEPT PHARMACEUTICALS, INC.v438200_ex31-3.htm

 

Exhibit 31.4

 

CERTIFICATIONS UNDER SECTION 302

 

I, Barbara G. Duncan, certify that:

 

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Intercept Pharmaceuticals, Inc.; and
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 29, 2016  
/s/ Barbara Duncan  
   
Barbara G. Duncan  
Chief Financial Officer  
(Principal Financial Officer)